GlassScriptPhysician profile
Lydia B Alexander
NPI 1679987515
$1,932.73
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $88.26 · 2021: $326 · 2022: $797 · 2023: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.19 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $481.85 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Evofem Biosciences, INC. | $193.38 | 2021-2023 | Phexxi |
| Organon LLC | $186.79 | 2021-2023 | Nexplanon |
| Myovant Sciences INC. | $161.91 | 2021-2022 | |
| Agile Therapeutics, INC. | $159.82 | 2021-2023 | Twirla |
| Avion Pharmaceuticals | $106.99 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.28 | 2019-2022 | |
| Coopersurgical, INC. | $94.49 | 2019-2023 | Summit Doppler |
| Mayne Pharma Commercial LLC | $79.68 | 2022 | |
| Merck Sharp & Dohme LLC | $77.99 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $74.17 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $68.61 | 2023 | Myfembree |
| Glaxosmithkline, LLC. | $59.70 | 2022-2023 | Shingrix |
| Medtronic, INC. | $45.27 | 2022 | |
| Allergan, INC. | $23.60 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.